BR9611234A - Composto formulação farmacêutica uso do composto e processos para tratamento de uma dor e para a preparação de compostos - Google Patents
Composto formulação farmacêutica uso do composto e processos para tratamento de uma dor e para a preparação de compostosInfo
- Publication number
- BR9611234A BR9611234A BR9611234A BR9611234A BR9611234A BR 9611234 A BR9611234 A BR 9611234A BR 9611234 A BR9611234 A BR 9611234A BR 9611234 A BR9611234 A BR 9611234A BR 9611234 A BR9611234 A BR 9611234A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- pain
- treating
- processes
- pharmaceutical formulation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/20—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Anesthesiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9503798A SE9503798D0 (sv) | 1995-10-27 | 1995-10-27 | New anaesthetic componds |
| SE9600329A SE9600329D0 (sv) | 1996-01-30 | 1996-01-30 | New anaesthetic compounds |
| PCT/SE1996/001361 WO1997015548A1 (en) | 1995-10-27 | 1996-10-23 | New [(3-alkoxy-phenoxy)-ethyl]-dialkylamine derivatives and their use as local anaesthetics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9611234A true BR9611234A (pt) | 1999-07-13 |
Family
ID=26662410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9611234A BR9611234A (pt) | 1995-10-27 | 1996-10-23 | Composto formulação farmacêutica uso do composto e processos para tratamento de uma dor e para a preparação de compostos |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US6310252B1 (pt) |
| EP (1) | EP0858445B1 (pt) |
| JP (1) | JP4101877B2 (pt) |
| KR (1) | KR100460652B1 (pt) |
| CN (1) | CN1113856C (pt) |
| AR (1) | AR004691A1 (pt) |
| AT (1) | ATE215061T1 (pt) |
| AU (1) | AU704635B2 (pt) |
| BR (1) | BR9611234A (pt) |
| CA (1) | CA2233489C (pt) |
| CZ (1) | CZ124198A3 (pt) |
| DE (1) | DE69620213T2 (pt) |
| DK (1) | DK0858445T3 (pt) |
| EE (1) | EE03963B1 (pt) |
| ES (1) | ES2174113T3 (pt) |
| HK (1) | HK1009437A1 (pt) |
| HU (1) | HUP9901212A3 (pt) |
| IL (1) | IL123916A (pt) |
| IS (1) | IS1932B (pt) |
| MY (1) | MY132329A (pt) |
| NO (1) | NO310614B1 (pt) |
| NZ (1) | NZ320757A (pt) |
| PL (1) | PL186783B1 (pt) |
| PT (1) | PT858445E (pt) |
| SI (1) | SI0858445T1 (pt) |
| SK (1) | SK282757B6 (pt) |
| TR (1) | TR199800714T2 (pt) |
| TW (1) | TW448142B (pt) |
| UA (1) | UA59347C2 (pt) |
| WO (1) | WO1997015548A1 (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7799337B2 (en) | 1997-07-21 | 2010-09-21 | Levin Bruce H | Method for directed intranasal administration of a composition |
| US6432986B2 (en) | 1997-07-21 | 2002-08-13 | Bruce H. Levin | Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches |
| SE9704031D0 (sv) * | 1997-11-05 | 1997-11-05 | Astra Ab | Novel formulation |
| SE9704770D0 (sv) * | 1997-12-19 | 1997-12-19 | Astra Ab | New use |
| SE9704834D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New process |
| SE9704835D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New compound |
| JP2000302737A (ja) * | 1999-04-16 | 2000-10-31 | Shiseido Co Ltd | 二置換ベンゼン誘導体 |
| US8473062B2 (en) | 2008-05-01 | 2013-06-25 | Autonomic Technologies, Inc. | Method and device for the treatment of headache |
| US8412336B2 (en) | 2008-12-29 | 2013-04-02 | Autonomic Technologies, Inc. | Integrated delivery and visualization tool for a neuromodulation system |
| US9012477B2 (en) | 2009-01-06 | 2015-04-21 | Nuvo Research Inc. | Method of treating neuropathic pain |
| US8494641B2 (en) | 2009-04-22 | 2013-07-23 | Autonomic Technologies, Inc. | Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism |
| US9320908B2 (en) | 2009-01-15 | 2016-04-26 | Autonomic Technologies, Inc. | Approval per use implanted neurostimulator |
| MX2012008168A (es) | 2010-01-14 | 2013-02-07 | Nuvo Res Inc | Formulaciones anestesicas locales que forman solidos para control del dolor. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1173136A (fr) | 1955-11-16 | 1959-02-20 | Rech S Et Tech Appliquees | Dérivés tertio-amino-alcoxylés du benzène et leur procédé de préparation |
| CH380746A (de) * | 1958-11-06 | 1964-08-15 | Ciba Geigy | Verfahren zur Herstellung neuer sekundärer Amine |
| GB1027611A (en) * | 1962-01-04 | 1966-04-27 | May & Baker Ltd | Phenoxy- and phenylthio-alkylamines and acid addition salts thereof |
| US3205136A (en) * | 1962-12-24 | 1965-09-07 | Smith Kline French Lab | Antidepressant phenyloxyalkylamines |
| DE3233828A1 (de) | 1982-09-11 | 1984-03-15 | Basf Ag, 6700 Ludwigshafen | Aryloxyalkylamine, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses |
-
1996
- 1996-10-14 AR ARP960104736A patent/AR004691A1/es unknown
- 1996-10-15 TW TW085112594A patent/TW448142B/zh not_active IP Right Cessation
- 1996-10-23 DE DE69620213T patent/DE69620213T2/de not_active Expired - Lifetime
- 1996-10-23 AU AU73561/96A patent/AU704635B2/en not_active Ceased
- 1996-10-23 TR TR1998/00714T patent/TR199800714T2/xx unknown
- 1996-10-23 JP JP51653997A patent/JP4101877B2/ja not_active Expired - Fee Related
- 1996-10-23 UA UA98042083A patent/UA59347C2/uk unknown
- 1996-10-23 CN CN96197845A patent/CN1113856C/zh not_active Expired - Fee Related
- 1996-10-23 BR BR9611234A patent/BR9611234A/pt not_active IP Right Cessation
- 1996-10-23 SI SI9630469T patent/SI0858445T1/xx unknown
- 1996-10-23 EP EP96935752A patent/EP0858445B1/en not_active Expired - Lifetime
- 1996-10-23 NZ NZ320757A patent/NZ320757A/xx not_active IP Right Cessation
- 1996-10-23 WO PCT/SE1996/001361 patent/WO1997015548A1/en not_active Application Discontinuation
- 1996-10-23 US US08/776,620 patent/US6310252B1/en not_active Expired - Fee Related
- 1996-10-23 SK SK553-98A patent/SK282757B6/sk unknown
- 1996-10-23 AT AT96935752T patent/ATE215061T1/de active
- 1996-10-23 CA CA002233489A patent/CA2233489C/en not_active Expired - Fee Related
- 1996-10-23 IL IL12391696A patent/IL123916A/en not_active IP Right Cessation
- 1996-10-23 HU HU9901212A patent/HUP9901212A3/hu unknown
- 1996-10-23 PT PT96935752T patent/PT858445E/pt unknown
- 1996-10-23 DK DK96935752T patent/DK0858445T3/da active
- 1996-10-23 KR KR10-1998-0703023A patent/KR100460652B1/ko not_active IP Right Cessation
- 1996-10-23 EE EE9800088A patent/EE03963B1/xx not_active IP Right Cessation
- 1996-10-23 PL PL96326425A patent/PL186783B1/pl not_active IP Right Cessation
- 1996-10-23 ES ES96935752T patent/ES2174113T3/es not_active Expired - Lifetime
- 1996-10-23 CZ CZ981241A patent/CZ124198A3/cs unknown
- 1996-10-25 MY MYPI96004455A patent/MY132329A/en unknown
-
1998
- 1998-03-25 IS IS4702A patent/IS1932B/is unknown
- 1998-04-23 NO NO19981825A patent/NO310614B1/no not_active IP Right Cessation
- 1998-09-01 HK HK98110334A patent/HK1009437A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9610248A (pt) | Composto composição farmacêutica processos para o tratamento da dor e para a preparação de um composto e uso do composto | |
| BR9612204A (pt) | Composto uso do composto composição farmacêutica e processo para preparação do composto e para o tratamento de dor | |
| BR9507656A (pt) | Composto utilização de um composto composição farmacéutica e processos para o tratamento de um paciente que sofre de dor e para a preparação de um composto | |
| BR9609780A (pt) | Composto uso de um composto processo para o tratamento de condições composição farmacêutica processos para preparar uma composição farmacêutica e para preparar um composto | |
| BR9503812A (pt) | Composto composição farmacêutica utilização método de tratamento de um ser humano processo para a preparação de um composto | |
| BR9702147A (pt) | Composição farmacéutica uso de uma composição farmacéutica e processo para o tratamento da dor associada com escarificação periodontal e para a preparação de uma composição farmacéutica | |
| BR9609467A (pt) | Composto uso de um composto composição farmacéutica e processos para preparação de um composto e tratamento de distúrbios de agregação planquetária | |
| BR9601061A (pt) | Composto formulação farmacêutica processos para tratar dor de enxaqueca e para a ativação de receptores | |
| BR9611986A (pt) | Compostos processo para a preparação dos mesmos composição farmcéutica e utilização dos compostos | |
| BR9602933A (pt) | Compostos processos para preparação de composto e de composição farmacêutica e composto | |
| BR9602705A (pt) | Composto composição farmacéutica processo para a preparação de um composto e uso | |
| BR9608956A (pt) | Composto composição farmacéutica e processos para aliviar a dor e para preparar um composto | |
| BR9600821A (pt) | Composto formulação farmacêutica e processo para a preparação de um composto | |
| BR9100435A (pt) | Composto,composicao farmaceutica,uso,metodo de tratamento de um animal,processos para a preparacao da um composto e de uma composicao farmaceutica | |
| BR9609701A (pt) | Composição farmacéutica composto e processo para a preparação de compostos | |
| BR9505610A (pt) | Composto composição farmacéutica processo para a preparação de um composto uso e método de tratar inflamação e dor | |
| BR9408148A (pt) | Processo para tratamento de arritmia composto e formulação farmacêutica | |
| BR9406128A (pt) | Uso de um composto processo para o tratamento e/ou prevençao de distúrbios psicóticos composto composiçao farmacêutica processos para a preparaçao de um composto e de uma composiçao farmacêutica | |
| BR9608908A (pt) | Composto composição farmacêutica processos para aliviar dor e para preparar um composto | |
| BR9711311A (pt) | Composto composi-Æo farmac-utica uso de um composto e processos para a prepara-Æo de compostos e para tratamento de um mamifero incluindo o homem | |
| BR9502471A (pt) | Composto de guanidina processo para preparar um composto de guanidina composição farmaceutica uso de um composto de guanidina método para o tratamento profilático ou terapêutico de doenças e processo para preparar uma composição farmacêutica | |
| BR9506473A (pt) | Composto processo para a preparação de compostos utilização de um composto composição farmacêutica e processo para o tratamento de infecções anti-fúngicas | |
| BR9602150A (pt) | Compostos processo para sua preparação processo para a produção de uma formulação farmacêutica formulação farmacêutica e uso | |
| BR9609327A (pt) | Novos derivados de oxazolidinona processos para sua preparação e agentes farmacêuticos que contêm estes compostos | |
| BR9611234A (pt) | Composto formulação farmacêutica uso do composto e processos para tratamento de uma dor e para a preparação de compostos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB36 | Technical and formal requirements: requirement - article 36 of industrial property law | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1882 DE 30/01/2007. |